Valion Bio (TIVC) Live Share Price, Invest From India

Valion Bio Stock Performance

as on April 28, 2026 at 6:59 am IST

Day's Low
$1.23
Day's Price Range
$1.39
$1.39
11.51%
Downside
52 Week's Low
52 Week's High
$0.72
52-Week Price Range
$2.70
$1.39
48.08%
Downside
94.24%
Upside

Valion Bio share price movements today

Previous Close: $1.33
Open: $1.27
Volume: 956.5K
Day's Low - High: $1.23 - $1.39
52 Week Low - High: $0.72 - $2.70

Valion Bio Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Valion Bio Stock Fundamentals & Key Indicators

Check Valion Bio market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

Return On Equity TTM

0.00%

Valion Bio vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Valion Bio with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Valion Bio	NA	$-	NA	NA	0.00%	0.00%
Boston Scientific	Buy	$64.8B	7.27%	18.86	70.37%	0.00%
Stryker	StrongBuy	$123.5B	20.60%	34.32	65.52%	1.09%
Edwards Lifesciences	StrongBuy	$59.8B	-8.78%	58.76	78.13%	0.00%
Medtronic	Buy	$130.0B	-14.84%	24.84	66.69%	2.82%

See all

Valion Bio Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-1	-2	-1	-1	-1	-1	-1	-1	-2	-2
Net Profit Margin	-624.11%	-628.29%	-443.41%	-904.29%	-1135.71%	-820.56%	-2145.71%	-2245.35%	-1778.08%	943.38%

Valion Bio Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	1	1	1	0	0
Gross Profit	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-4	-3	-8	-10	-8	-5	-8
Net Profit Margin	-987.62%	-423.14%	-728.47%	-548.70%	-701.02%	-725.00%	-2324.08%

Global Institutional Holdings in Valion Bio

Check out the Institutions with significant holdings in Valion Bio.

Funds	Holdings
Ground Swell Capital, LLC	0.00%
Tower Research Capital LLC	0.07%
Vanguard Group Inc	0.00%
DRW Securities, LLC	0.00%
Marex Group PLC	1.61%

See all

Insights on Valion Bio

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, TIVC stock has moved up by 14.7%
NO EFFECT
Against Peers
In the last 3 years, Tivic Health Systems Inc has experienced a drawdown of -99.4%, however Boston Scientific Corp. resisted the overall trend and outperformed by 95.0%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 11.4% return, outperforming this stock by 90.8%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 7 quarters, -1.26M → -2.84M (in $), with an average decrease of 15.1% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 146.0K → -302.0K (in $), with an average decrease of 306.9% per quarter

About Valion Bio

Tivic Health Systems, Inc. is a late-stage therapeutics company. The Company’s biopharma program is focused on advancing its drug product candidate, Entolimod, into manufacturing, conducting process validation utilizing the output of such manufacturing with the intent of selling the biologic compounds either inside or outside the United States. The Company’s bioelectronic program is focused on developing non-invasive medical devices that influence biologic functions associated with various diseases and conditions. It has an over-the-counter device, ClearUP, that treats sinus pain and pressure. The Company’s Toll-like Receptor 5 (TLR5) program’s lead product candidate is the late-stage TLR5 agonist, Entolimod, to treat acute radiation syndrome (ARS) and for remediating side effects of medical radiation and chemotherapy. The Company offers contract development and manufacturing organization through its subsidiary Velocity Bioworks, Inc.

Organisation

Valion Bio

FAQs

What is Valion Bio share price today?

Valion Bio share price today is $1.39 as on April 28, 2026 at 1:29 am IST at the close of the market. Valion Bio share today touched a day high of $1.39 and a low of $1.23.

What is the 52 week high and 52 week low for Valion Bio share?

Valion Bio share touched a 52 week high of $2.70 on December 11, 2025 and a 52 week low of $0.72 on March 9, 2026. Valion Bio stock price today i.e. April 28, 2026 at 1:29 am IST is closed at $1.39,which is 48.52% down from its 52 week high and 92.60% up from its 52 week low.

How to invest in Valion Bio Stock (TIVC) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Valion Bio on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Valion Bio Stock (TIVC) from India?

Indian investors can start investing in Valion Bio (TIVC) shares with as little as ₹94.04000091552734 or $1 (as of November 13, 2026 at 3:58 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹940.40 in Valion Bio stock (as per the Rupee-Dollar exchange rate as on November 13, 2026 at 3:58 am IST). Based on Valion Bio share’s latest price of $1.39 as on April 28, 2026 at 1:29 am IST, you will get 7.1942 shares of Valion Bio. Learn more about fractional shares .